196 related articles for article (PubMed ID: 20164789)
1. Effects of sex hormones on cardiac repolarization.
Yang PC; Clancy CE
J Cardiovasc Pharmacol; 2010 Aug; 56(2):123-9. PubMed ID: 20164789
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
[TBL] [Abstract][Full Text] [Related]
3. Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes.
Kurokawa J; Kodama M; Clancy CE; Furukawa T
Pharmacol Ther; 2016 Dec; 168():23-28. PubMed ID: 27595633
[TBL] [Abstract][Full Text] [Related]
4. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence.
Ebert SN; Liu XK; Woosley RL
J Womens Health; 1998 Jun; 7(5):547-57. PubMed ID: 9650155
[TBL] [Abstract][Full Text] [Related]
5. Influence of steroid hormones on ventricular repolarization.
Salem JE; Alexandre J; Bachelot A; Funck-Brentano C
Pharmacol Ther; 2016 Nov; 167():38-47. PubMed ID: 27452340
[TBL] [Abstract][Full Text] [Related]
6. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human.
Cheng J
Fundam Clin Pharmacol; 2006 Feb; 20(1):1-8. PubMed ID: 16448390
[TBL] [Abstract][Full Text] [Related]
7. Drugs for men and women - how important is gender as a risk factor for TdP?
Coker SJ
Pharmacol Ther; 2008 Aug; 119(2):186-94. PubMed ID: 18472167
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias.
Vos MA; van Opstal JM; Leunissen JD; Verduyn SC
Pharmacol Ther; 2001; 92(2-3):109-22. PubMed ID: 11916532
[TBL] [Abstract][Full Text] [Related]
9. Non-genomic action of sex steroid hormones and cardiac repolarization.
Kurokawa J; Furukawa T
Biol Pharm Bull; 2013; 36(1):8-12. PubMed ID: 23302631
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study.
Yang PC; Kurokawa J; Furukawa T; Clancy CE
PLoS Comput Biol; 2010 Jan; 6(1):e1000658. PubMed ID: 20126530
[TBL] [Abstract][Full Text] [Related]
11. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
Drici MD; Clément N
Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
[TBL] [Abstract][Full Text] [Related]
12. Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology.
Jonsson MK; Vos MA; Duker G; Demolombe S; van Veen TA
Pharmacol Ther; 2010 Jul; 127(1):9-18. PubMed ID: 20462510
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps.
Hreiche R; Morissette P; Turgeon J
Gend Med; 2008 Jun; 5(2):124-35. PubMed ID: 18573480
[TBL] [Abstract][Full Text] [Related]
14. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced long QT syndrome in women.
Li G; Cheng G; Wu J; Zhou X; Liu P; Sun C
Adv Ther; 2013 Sep; 30(9):793-802. PubMed ID: 24085659
[TBL] [Abstract][Full Text] [Related]
17. Sex-Related Differences in Drug-Induced QT Prolongation and Torsades de Pointes: A New Model System with Human iPSC-CMs.
Huo J; Wei F; Cai C; Lyn-Cook B; Pang L
Toxicol Sci; 2019 Feb; 167(2):360-374. PubMed ID: 30247688
[TBL] [Abstract][Full Text] [Related]
18. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
19. Sex, hormones, and repolarization.
Pham TV; Rosen MR
Cardiovasc Res; 2002 Feb; 53(3):740-51. PubMed ID: 11861044
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
Eckardt L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
